EpiPaws
PrivateLast Round
Seed
Mar 24, 2025
Total Funding Raised
$275,000
Company Overview
EpiPaws operates in Healthcare & Life Sciences and is based in Fort Lauderdale, Florida. Its latest recorded funding round was a Seed round in March 2025.
EpiPaws is a biotechnology company that provides an epigenetic biomarker-based age test for dogs and cats, allowing pet owners to determine their pet's age and gain health insights.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, E-commerce
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiPaws Comparables
Compare EpiPaws with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProsperK9 | 86% | |
| Omi Health | 85% | |
| Woofgenix Inc. | 82% |
For institutional investors. Book with your work email.
EpiPaws Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 24, 2025 | ||||
| Grant | Jan 31, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EpiPaws Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Active Capital | Grant |
| New World Angels | Seed |
| Purina (9 Square Ventures) | Grant |
| Active Capital | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 173% MoM, reaching 6.2K.
- Dec 15, 2025
Launched HealthScore, an at-home biological age test for pets.
For institutional investors. Book with your work email.
EpiPaws Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EpiPaws's valuation, stock price, and market status.
Is EpiPaws a public or private company?
EpiPaws is a private company.
What is the current stock price of EpiPaws?
EpiPaws is a private company, so its shares have no public market price. Caplight tracks EpiPaws's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EpiPaws worth (valuation)?
Valuation information for EpiPaws is not publicly available.
Can I buy EpiPaws stock?
EpiPaws shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EpiPaws's last funding round?
EpiPaws's most recent funding round was Seed on March 24, 2025.
Who are the main investors in EpiPaws?
Key investors in EpiPaws include Active Capital, New World Angels, Purina (9 Square Ventures), Active Capital.
Will EpiPaws IPO soon?
No public IPO plans have been announced for EpiPaws.
How can I track EpiPaws secondary market activity?
Caplight tracks bids, offers, and trades in EpiPaws's shares on secondary markets.